$ADMP cnn.com/2021/04/29/india/in... The covid situation in India is indescribable. Unofficial data indicate about half a billion people have been infected and more than a million have died so far. It will affect the global economy for sure, which hasn’t been priced yet. We need Tempol in the potential therapeutic mix. Adamis needs to start the Tempol trial ASAP. If you check the LinkedIn profile of Ron Moss, he posted two positions about a month ago - one for a Clinical Trial Manager and the other for a QC Manager, which indicates Tempol clinical trial is starting any day. Zimhi resubmission is coming next month as well. Next week and the week after look very promising!
1 Like